Find a Tender
complete
Official procurement procedure
REMDESIVIR INFUSION
No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Southern Health and Social Care Trust: "REMDESIVIR INFUSION". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Southern Health and Social Care Trust | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Southern Health and Social Care Trust
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Southern Health and Social Care Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
Not availableNo published reports
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 11 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthoritySouthern Health and Social Care Trust | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published13 May 2026, 14:09 BST | Last source update13 May 2026, 14:09 BST | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-068d6d | ||
What is being bought
The contract is for the supply of Remdesivir infusion for the treatment of viral disease for a period of 3 years
What changed
From the official release history
- Official notice release published
13 May 2026, 14:09 BST - Official notice release published
29 Apr 2026, 08:51 BST - Status changed to complete
29 Apr 2026, 08:29 BST - Official notice release published
29 Apr 2026, 08:29 BST - Buyer information updated
29 Apr 2026, 08:29 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
13 May 2026, 14:09 BST - Award active
Not published · Not published - Contract active
Signed 13 May 2026, 00:00 BST · £300,000
Commercial outcome and competition
Awards GILEAD SCIENCES LTD Not published · Not published · active |
Contracts Contract £300,000 · signed 13 May 2026, 00:00 BST · active Contract period: 14 May 2026, 00:00 BST — 13 May 2029, 23:59 BST |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
Southern Health and Social Care Trust
Contracting authority GB-PPON-PJCC-1957-RCGPDocuments (1)
Official links; attachments are not copied
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleSingle supplier - intellectual property or exclusive rights
As per Section 41 of the PA2023, a direct award is made in line with Schedule 5 of the PA2023 paragraph 5 "due to the supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required,"
This product is the only commercially available from one supplier and no competition or alternative exists for this product |